Are We Giving Optimal Dose of Efavirenz?

Authors

  • Evy Yunihastuti Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.

Abstract

Antiretroviral is one of the drugs that extensively been studied for its drug-to- drug interaction. Its long term used and the fact that many HIV-infected patients came in the late stage of disease make polypharmacy is unavoidable.Efavirenz is one of antiretroviral drugs that widely used in HIV-infected patients age more than 3 years old in many countries. Latest Indonesian antiretroviral guidelines recommend a combination of tenofovir, lamivudine and efavirenz given orally in one daily dose as the  preferred  primary  fixed-drug  combination treatment. This recommendation is based on many evidence supporting efficacy, tolerability, price, pregnancy safety, simplicity and the availability of the drug that will support the continuing comprehensive care for HIV-infected patients in primary care level.

Downloads

Published

2016-09-19

How to Cite

Yunihastuti, E. (2016). Are We Giving Optimal Dose of Efavirenz?. Acta Medica Indonesiana, 48(1), 1. Retrieved from https://actamedindones.org/index.php/ijim/article/view/130

Issue

Vol. 48 No. 1 (2016): Acta Medica Indonesiana

Section

EDITORIAL

License

Copyright

The authors who publish in this journal agree to the following requirements:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.